The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary

Short summary

In 2016, the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) was 121 per million population (pmp) across 36 European countries, with significant variation (29-251 pmp). Haemodialysis was the primary treatment for 84% of patients starting RRT.

AI-generated from the title and abstract; the full text is not read.